Neuromedin 15 mg/ml 10 ampoules

Product Details

Neuromedin 15 mg/ml: A Metabolic Neuroprotectant for Nerve Tissue Regeneration and Cognitive Rehabilitation

Name: Buy Neuromedin 15 mg/ml 10 ampoules — injectable metabolic n
Price: 160.0 EUR
Availability: InStock

Neuronal injury — whether an acute vascular catastrophe, a traumatic blow, or a slowly smoldering neurodegenerative process — is invariably accompanied by disrupted cellular energy metabolism, mitochondrial dysfunction, and the accumulation of toxic metabolic byproducts. Neuromedin 15 mg/ml is an injectable metabolic neuroprotectant containing citicoline (cytidine diphosphate choline) — a naturally occurring compound that serves as a pivotal intermediate in the synthesis of both cell membrane phospholipids and the neurotransmitter acetylcholine. The pack of 10 ampoules at 15 mg/ml is calibrated for a course of intensive therapy during the acute and recovery phases of neurological disease.

🧠 Biochemical Mechanism: Membrane Repair and Neurotransmission

Citicoline is an exogenous precursor of two molecules that are vital for neuronal function: phosphatidylcholine (the principal structural component of cell membranes) and acetylcholine (one of the major neurotransmitters responsible for memory, learning, and neuromuscular transmission). Its mechanism of action unfolds on several levels:

1. Cell Membrane Repair.

During ischemia or trauma, phospholipases degrade neuronal membrane phospholipids, liberating free fatty acids and triggering a cascade of secondary injury. Citicoline supplies the building blocks for the resynthesis of phosphatidylcholine and sphingomyelin, accelerating the restoration of membrane integrity and preventing the loss of intracellular contents.

2. Inhibition of the Glutamate-Calcium Cascade.

Citicoline reduces glutamate release from presynaptic terminals and attenuates calcium influx into the postsynaptic neuron. This dampens the excitotoxic assault that constitutes the principal mechanism of neuronal death within the ischemic penumbra during stroke.

3. Antioxidant Defense.

Citicoline enhances the activity of endogenous antioxidant enzymes — superoxide dismutase and glutathione reductase — and diminishes the intensity of lipid peroxidation.

4. Stimulation of Cholinergic Transmission.

Citicoline increases acetylcholine synthesis in cholinergic neurons of the basal nuclei and cortex, thereby improving cognitive functions — memory, attention, and information processing speed.

5. Neuroplasticity.

The drug stimulates the sprouting (outgrowth of new processes) of surviving neurons and the formation of novel synaptic contacts, promoting the functional reorganization of damaged neuronal networks.

📋 Clinical Indications

Neuromedin is deployed in neurological, neurosurgical, and rehabilitative practice:

1. Acute Cerebrovascular Events:

Ischemic stroke in the hyperacute, acute, and recovery phases.
Hemorrhagic stroke (after hemodynamic stabilization and exclusion of ongoing bleeding).

2. Traumatic Brain Injury:

The acute phase of TBI (concussion, cerebral contusion).
Rehabilitation following severe TBI with cognitive deficits.

3. Cognitive Disorders:

Vascular dementia.
Post-traumatic and post-stroke cognitive impairment.
Age-related cognitive decline.

4. Peripheral Nervous System Disorders:

Diabetic polyneuropathy.
Alcoholic neuropathy.
Mononeuropathies (facial nerve, trigeminal nerve neuropathy).

5. Neurodegenerative Diseases:

Parkinson's disease (as part of combination therapy).
Alzheimer's disease (in the early stages).

💉 Administration and Dosing Regimen

Neuromedin is a clear, colorless, or faintly yellowish solution supplied in ampoules.

Route of Administration: Intramuscular or intravenous (slow bolus or drip infusion). The specific route depends on the acuity of the condition and is determined by the physician.
Single Dose: 15–30 mg/ml (1–2 ampoules).
Frequency: 1–2 times daily.
Course Duration: From 10 to 30 days, depending on the pathology.
- In acute stroke: IV drip at 30 mg/ml twice daily for 7–10 days, followed by IM administration for 10–14 days.
- In chronic diseases: IM at 15 mg/ml 1–2 times daily for 14–30 days.
Repeat Courses: 2–3 times per year, on a physician's recommendation.

⚠️ Contraindications and Precautionary Measures

Neuromedin is not prescribed in the setting of:

Individual hypersensitivity to citicoline or any excipient.
Hemorrhagic stroke in the hyperacute phase with ongoing bleeding.
Vagotonia (hypertonicity of the parasympathetic nervous system).
Pregnancy and breastfeeding.
Children and adolescents under 18 years of age.

📊 Tolerability Profile

Neuromedin is generally well tolerated. In rare instances, the following may occur:

Headache, mild dizziness.
Nausea, epigastric discomfort.
Allergic reactions (skin rash, pruritus).
Soreness and redness at the intramuscular injection site.
Transient lowering of blood pressure.

📦 Storage Conditions

Ampoules must be stored in a light-protected location at room temperature (not exceeding 25 °C / 77 °F). Do not freeze. Keep out of the reach of children.

📦Find out about the delivery to your country on WhatsApp

Important notice

The photograph is provided for product identification. Packaging design may vary by batch or market. This page provides general product information and does not replace the package leaflet, diagnosis, prescription or advice from a doctor or pharmacist.

More about this product